Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

Clinical trial NCT01609790 · COMPLETED

Trial details

NCT number: NCT01609790
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Giant Cell Glioblastoma Glioblastoma Gliosarcoma Oligodendroglioma Recurrent Brain Neoplasm Recurrent Glioblastoma

Start date: 2012-06-04
Primary completion: 2015-10-02
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.